SCHEMBL1775869

SCHEMBL1775869

CN1CCN(c2nccc3sc(Br)c(S(=O)(=O)Nc4ccccc4)c23)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
PKM P14618 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HRH4 Q9H3N8 2/20 0.39
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
HTR6 P50406 6/20 0.37
HTR1A P08908 2/20 0.37
HTR2A P28223 2/20 0.37
HTR7 P34969 2/20 0.37
HTR1D P28221 1/20 0.37
HTR1B P28222 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
HTR2C P28335 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1776644 0.99 LMNA (0.39) LMNAPKMSMN1; SMN2HRH4ADORA3
SCHEMBL1775987 0.91 HTT (0.39) LMNAPKMSMN1; SMN2HTR6HTR1A
Hydrochloric Acid SCHEMBL1774418 0.90 HTT (0.39) LMNAPKMSMN1; SMN2HTR6HTR1A
SCHEMBL1775387 0.82 HRH4 (0.39) HRH4HTR2ADRD3
SCHEMBL1775433 0.81 HTR6 (0.40) HTR6HTR1AHTR2AHTR7HTR1D
SCHEMBL1774845 0.78 HRH4 (0.37) HRH4HTR6HTR1AHTR2AHTR7
Hydrochloric Acid SCHEMBL1775293 0.78 HRH4 (0.36) HRH4HTR6HTR1AHTR2AHTR7
SCHEMBL1775401 0.77 HRH4 (0.45) LMNAPKMSMN1; SMN2HRH4ADORA3
SCHEMBL1776120 0.77 KIT (0.39) HTR6HTR2ADRD3
Hydrochloric Acid SCHEMBL1775562 0.76 KIT (0.38) HTR6HTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943639-B2 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss PROXIMAGEN LIMITED (GB) 2011-05-17 US claimed